PATIENTS
AuroLase for the
Ablation of Prostate
Cancer Tissue
PATIENTS
AuroLase for the
Ablation of Prostate
Cancer Tissue
AuroLase Therapy for prostate disease is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies. The company is currently conducting a multi-site clinical trial for prostate disease.
Tumor Ablation using AuroLase Therapy
AuroLase® Therapy combines the unique physical and optical properties of AuroShell® particles with a near-infrared laser source to thermally destroy cancer tissue without significant damage to surrounding healthy tissue. Nanospectra’s proprietary AuroShells circulate freely in the blood stream and collect in the tumor. With state of the art imaging technology, the clinician accurately identifies the lesion and positions the optical fiber probe via targeted MRI Ultrasound fusion technology. The diseased tissue is ablated while sparing the surrounding tissue.
Performed on an outpatient basis, the AuroLase procedure results in significantly fewer side effects enabling the patient to return to a normal lifestyle within days versus weeks. In addition, patients lose no follow-on clinical options.
AuroShell particles are investigational at this current time and only available through designated FDA sanctioned clinical study sites.
PATIENT RESOURCES
-
Black men in the United States have the nation’s highest prostate cancer incidence and mortality rates. PHEN’s mission is to eliminate the African American prostate cancer disparity and increase overall advocacy support and resources to wage a war on prostate cancer that will eventually lead to a cure for the disease for the benefit of all men.
-
We commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease but to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life, with the support they need to minimize physical and emotional suffering and to cope effectively throughout their cancer journeys.